Multiple sclerosis: Real-world long-term benefits of disease-modifying MS therapy

被引：1
|
作者：
Fyfe I.
机构：
来源：
Nature Reviews Neurology | 2016年 / 12卷 / 7期
关键词：
D O I：
10.1038/nrneurol.2016.76
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：372 / 372
相关论文
共 50 条
  • [31] The effect of national disease-modifying therapy subsidy policy on long-term disability outcomes in people with multiple sclerosis
    Claflin, Suzi B.
    Campbell, Julie A.
    Mason, Deborah F.
    Kalincik, Tomas
    Simpson-Yap, Steve
    Norman, Richard
    Butzkueven, Helmut
    Carroll, William M.
    Palmer, Andrew J.
    Blizzard, C. Leigh
    van der Mei, Ingrid
    Taylor, Bruce, V
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (05) : 831 - 841
  • [32] Treatment switches of disease-modifying therapies in people with multiple sclerosis: long-term experience from the German MS Registry
    Frahm, Niklas
    Ellenberger, David
    Stahmann, Alexander
    Fneish, Firas
    Lueftenegger, Daniel
    Salmen, Hans C.
    Schirduan, Ksenija
    Schaak, Tom P. A.
    Flachenecker, Peter
    Kleinschnitz, Christoph
    Paul, Friedemann
    Krefting, Dagmar
    Zettl, Uwe K.
    Peters, Melanie
    Warnke, Clemens
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2024, 17
  • [33] Multiple sclerosis disease-modifying therapy and pregnancy
    Miller, Aaron E.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (06) : 715 - 716
  • [34] Disease-Modifying Therapy of Pediatric Multiple Sclerosis
    Tanuja Chitnis
    Neurotherapeutics, 2013, 10 : 89 - 96
  • [35] EMERGENCY ROOM UTILIZATION AMONG MULTIPLE SCLEROSIS PATIENTS TREATED WITH DISEASE-MODIFYING THERAPY IN A REAL-WORLD HYBRID CLAIMS DATABASE
    Kuranz, S.
    VALUE IN HEALTH, 2024, 27 (06) : S215 - S215
  • [36] Disease-Modifying Therapy of Pediatric Multiple Sclerosis
    Chitnis, Tanuja
    NEUROTHERAPEUTICS, 2013, 10 (01) : 89 - 96
  • [37] Impact of adherence to disease modifying therapies on long-term clinical and economic outcomes in multiple sclerosis: A claims analysis of real-world data
    Amezcua, Lilyana
    Livingston, Terrie
    Hayward, Brooke
    Zhou, Jia
    Williams, Mitzi J.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 77
  • [38] Comparative effectiveness of long-term users of disease-modifying therapy
    Salter, A.
    Tang, Y.
    Hornung, L.
    Kolodny, S.
    Hurtukova, D.
    Glenski, S.
    Cofield, S.
    Zhang, X.
    Cutter, G.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 309 - 310
  • [39] Long-Term Effectiveness of Fingolimod for Multiple Sclerosis in a Real-World Clinical Setting
    Uzunkopru, Cihat
    Beckmann, Yesim
    Ture, Sabiha
    EUROPEAN NEUROLOGY, 2021, 84 (03) : 200 - 205
  • [40] Long-term safety and real-world effectiveness of fingolimod in relapsing multiple sclerosis
    Druart, Charlotte
    El Sankari, Souraya
    van Pesch, Vincent
    PATIENT-RELATED OUTCOME MEASURES, 2018, 9 : 1 - 10
12345